Projecting the future diabetes population size and related costs for the U.S.

scientific article published on December 2009

Projecting the future diabetes population size and related costs for the U.S. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DC09-0459
P932PMC publication ID2782981
P698PubMed publication ID19940225
P5875ResearchGate publication ID40033447

P2093author name stringAnirban Basu
Elbert S Huang
Michael O'Grady
James C Capretta
P2860cites workEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study InvestigatorsQ28144781
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002Q28196337
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupQ29619460
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetesQ35634210
Preventing foot ulcers in patients with diabetesQ36006260
The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centersQ36295307
Improving and sustaining diabetes care in community health centers with the health disparities collaborativesQ37002563
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projectionsQ39474763
Using clinical information to project federal health care spendingQ39950220
Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge MeetingQ40209606
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).Q40471646
Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetesQ40586493
Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.Q40679527
Implications of population growth on prevalence of diabetes. A look at the futureQ41122102
UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.Q44053922
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).Q44400392
The disproportionate burden of diabetes in African-American and Hispanic populations.Q46052059
Model of complications of NIDDM. I. Model construction and assumptions.Q50957725
Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.Q54611974
Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989Q74093722
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)2225-2229
P577publication date2009-12-01
P1433published inDiabetes CareQ5270111
P1476titleProjecting the future diabetes population size and related costs for the U.S.
P478volume32

Reverse relations

cites work (P2860)
Q27312839"Everyone else gets ice cream here more often than I do--It burns me up"--Perspectives on Diabetes Care from Nursing Home Residents and their Doctors
Q384499925-hydroxytryptamine medications for the treatment of obesity
Q40019611A Comparison of the Use and Quality of Antidiabetic Medication Regimens Between Non-Hispanic Black and White Adults With Uncontrolled Type 2 Diabetes in the US: NHANES 2003-2012.
Q47735766A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care
Q34214405A feasibility study to develop a diabetes prevention program for young adults with prediabetes by using digital platforms and a handheld device.
Q37560339A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus
Q37994123A review and critical analysis of professional societies' guidelines for pharmacologic management of type 2 diabetes mellitus
Q37527258Adropin deficiency is associated with increased adiposity and insulin resistance
Q30356946Adult tissue sources for new β cells.
Q35207929An internet-based diabetes management platform improves team care and outcomes in an urban Latino population
Q37785961An overview of temperature monitoring devices for early detection of diabetic foot disorders.
Q37670101Application of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012
Q44994017Association between self-reported type 2 diabetes mellitus and physical function in older American Indians.
Q50532480Association of a polymorphism of BTN2A1 with type 2 diabetes mellitus in Japanese individuals.
Q34139042Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
Q36396719Automated Telephone Self-Management Support for Diabetes in a Low-Income Health Plan: A Health Care Utilization and Cost Analysis
Q37278068Barriers and potential solutions to providing optimal guideline-driven care to patients with diabetes in the U.S.
Q35957969Behavioral Change Challenges in the Context of Center-Based Cardiac Rehabilitation: A Qualitative Study
Q84638069Beyond The Affordable Care Act: Achieving Real Improvements In Americans’ Health
Q37940337Building a pipeline of training for behavioral diabetes researchers and clinicians: a call for national dialogue.
Q44805963Building capacity to reduce disparities in diabetes: training community health workers using an integrated distance learning model
Q34485306Burning through the pain: treatments for diabetic neuropathy.
Q92635837COMP-Ang1 Stabilizes Hyperglycemic Disruption of Blood-Retinal Barrier Phenotype in Human Retinal Microvascular Endothelial Cells
Q34548577Can Food Stamps help to reduce Medicare spending on diabetes?
Q44902330Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs
Q37988796Cardiovascular autonomic neuropathies as complications of diabetes mellitus
Q34996879Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND.
Q37248181Challenges in Diabetes Care: Can Digital Health Help Address Them?
Q42859155Characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large US claims database
Q36705829Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer
Q35179973Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control
Q35094982Cognitive decline and the default American lifestyle
Q26851536Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force
Q40955409Commentary: Why Was Inhaled Insulin a Failure in the Market?
Q36533473Community-Based Diabetes Screening and Risk Assessment in Rural West Virginia
Q33580574Community-Based Health Education Programs Designed to Improve Clinical Measures Are Unlikely to Reduce Short-Term Costs or Utilization Without Additional Features Targeting These Outcomes
Q92647760Comparing the Lifestyle Interventions for Prediabetes: An Integrated Microsimulation and Population Simulation Model
Q37363045Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial.
Q35805646Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk.
Q41546338Complications in ankle fracture surgery
Q33979810Consumer engagement for diabetes technology: easier said than done
Q88706555Cost-Effectiveness of a Community-Based Diabetes Prevention Program with Participation Incentives for Medicaid Beneficiaries
Q36282573Cost-effectiveness of an electronic medical record based clinical decision support system.
Q41158273Cost-effectiveness of becaplermin gel on wound healing of diabetic foot ulcers
Q60044353Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review
Q35997327Cross-site evaluation of the Alliance to Reduce Disparities in Diabetes: clinical and patient-reported outcomes.
Q35924648Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
Q38079568Declines in lower extremity amputation in the US Medicare population, 2000-2010.
Q37290650Deletion of retinoic acid receptor β (RARβ) impairs pancreatic endocrine differentiation.
Q35497064Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs
Q42338492Diabetes and its drivers: the largest epidemic in human history?
Q47301502Diabetes and the Motivated Patient: Understanding Perlocutionary Effect in Health Communication.
Q37855347Diabetes management in the nursing home: a systematic review of the literature
Q40324265Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease.
Q37102832Diabetes prevention: can insulin secretagogues do the job?
Q43039163Diabetic maculopathy and retinopathy. Functional and sociomedical significance
Q35897315Differential synthesis and action of TGFß superfamily ligands in mouse and rat islets
Q37668273Effects of long-term testosterone therapy on patients with "diabesity": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes
Q45545993Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes
Q55417923Endometrial cancer in an increasingly obese population: Exploring alternative options when surgery may not cut it.
Q38744396Enhancing Glycemic Control via Detection of Insulin Using Electrochemical Impedance Spectroscopy
Q51746515Estimated Cost Savings: Everyone with Diabetes Counts (EDC) Program.
Q33634067Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method
Q37706116Ethanolic Extract of Butea monosperma Leaves Elevate Blood Insulin Level in Type 2 Diabetic Rats, Stimulate Insulin Secretion in Isolated Rat Islets, and Enhance Hepatic Glycogen Formation
Q36991963Evidence for the benefit of exercise therapy in patients with type 2 diabetes
Q35210531Evidence-based approach for managing hypertension in type 2 diabetes
Q38032321Exenatide extended-release: a review of its use in type 2 diabetes mellitus
Q47346393Exposures Associated with Minority High Schoolers' Predisposition for Health Science
Q91986471Failing to plan and planning to fail. Can we predict the future growth of demand on UK Eye Care Services?
Q90411821Fiber type-specific effects of acute exercise on insulin-stimulated AS160 phosphorylation in insulin-resistant rat skeletal muscle
Q90103170Forecasting the Prevalence of Diabetes Mellitus Using Econometric Models
Q34419221Forecasting the burden of type 2 diabetes in Singapore using a demographic epidemiological model of Singapore
Q38095825From gut changes to type 2 diabetes remission after gastric bypass surgeries
Q34155197Gender differences in diabetes-related lower extremity amputations
Q35175717Getting big on BPA: role for BPA in obesity?
Q34312678Global obesity: trends, risk factors and policy implications
Q37757983Glucose lowering and cardiovascular disease: what do we know and what should we do?
Q34507025Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study
Q38642356Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model
Q35885472Health behavior change following chronic illness in middle and later life
Q36424159Heme Oxygenase-1 Promotes Delayed Wound Healing in Diabetic Rats
Q35907775High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury
Q38924695How to defuse a demographic time bomb: the way forward?
Q40253182Hypothalamic Inflammation: Is There Evidence for Human Obesity?
Q34073450Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes
Q33652884Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes
Q34374336Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors
Q43091486Individualizing care for the many: the evolving role of professional continuous glucose monitoring systems in clinical practice
Q35285830Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet?
Q33753663Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data
Q35749939Intestinal methane production in obese individuals is associated with a higher body mass index
Q30582848Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort
Q36105649LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.
Q85212413Limitations of the db/db mouse in translational wound healing research: Is the NONcNZO10 polygenic mouse model superior?
Q33644153Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response
Q33607693Low-protein diet for the prevention of renal failure
Q60313151Lysozyme-Antimicrobial Peptide Fusion Protein Promotes the Diabetic Wound Size Reduction in Streptozotocin (STZ)-Induced Diabetic Rats
Q26745818Management of diabetes mellitus in older people with comorbidities
Q36523427Management of type-2 diabetes mellitus in adults: focus on individualizing non-insulin therapies
Q48010750Mechanisms and consequences of carbamoylation
Q38964377Medical Care Expenditures for Individuals with Prediabetes: The Potential Cost Savings in Reducing the Risk of Developing Diabetes
Q36710350Metabolic disruption in context: Clinical avenues for synergistic perturbations in energy homeostasis by endocrine disrupting chemicals
Q33735548Mobile phone technologies and advanced data analysis towards the enhancement of diabetes self-management
Q33969384Modeling and calibration for exposure to time-varying, modifiable risk factors: the example of smoking behavior in India
Q37368036Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010-2030.
Q36366129Mortality rates in trials of subjects with type 2 diabetes
Q34645677Multifocal Electroretinograms Predict Onset of Diabetic Retinopathy in Adult Patients with Diabetes
Q47112812Multimodal Assessment of Mesenchymal Stem Cell Therapy for Diabetic Vascular Complications
Q27693882Nanosensors and nanomaterials for monitoring glucose in diabetes
Q38563071National Strategies to Decrease the Burden of Diabetes and Its Complications
Q38807857Novel Therapeutics for Diabetes: Uptake, Usage Trends, and Comparative Effectiveness
Q36159133Novel approach to inpatient glucometric monitoring and variability in a community hospital setting
Q35205374On the decision rules of cost-effective treatment for patients with diabetic foot syndrome
Q42688606Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes
Q37840269Patient adherence to medication requirements for therapy of type 2 diabetes.
Q93018588Patient-reported quality of life and hand disability in elderly patients after a traumatic hand injury - a retrospective study
Q35179946Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial
Q36417765Physical fitness, weight, smoking, and exercise patterns in young adults
Q38777574Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease
Q38051576Pomegranate: a fruit that ameliorates metabolic syndrome
Q38187290Predicting adherence to diabetic eye examinations: development of the compliance withAnnual Diabetic Eye Exams Survey
Q33714839Primary care shortages: strengthening this sector is urgently needed, now and in preparation for healthcare reform
Q33972551Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
Q35798114Prioritization of care in adults with diabetes and comorbidity
Q47564193Program ACTIVE: Cognitive Behavioral Therapy to Treat Depression in Adults With Type 2 Diabetes in Rural Appalachia
Q40058808Projecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach
Q35705650Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis
Q40020513Projection of prediabetes and diabetes population size in Singapore using a dynamic Markov model
Q39449345Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040.
Q55467652Projection of the future diabetes burden in the United States through 2060.
Q38614811Quality improvement in diabetes--successful in achieving better care with hopes for prevention
Q42275780Racial/ethnic disparities in chronic diseases of youths and access to health care in the United States
Q37330074Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens
Q37631209Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study
Q34437639Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial
Q39307436Reaching the Unreachable: Novel Approaches to Telemedicine Screening of Underserved Populations for Vitreoretinal Disease
Q33735026Relationship of meeting physical activity guidelines with health-related utility.
Q38002135Retinal neuropathy precedes vasculopathy in diabetes: a function-based opportunity for early treatment intervention?
Q43080336Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis
Q36139126Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Q34239784Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
Q37835610Screening tests for renal impairment in patients with type 2 diabetes: the what, when, and how.
Q36932435Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance
Q42816439Self-Assembled Wound Dressings Silence MMP-9 and Improve Diabetic Wound Healing In Vivo
Q36157215Setbacks in diet adherence and emotional distress: a study of older patients with type 2 diabetes and their spouses
Q38440143Significant J-shaped association between body mass index (BMI) and diabetic foot ulcers.
Q37394557Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes
Q37181044Social Support Groups in the Maintenance of Glycemic Control after Community-Based Intervention
Q36054218Social support and self-care activities among the elderly patients with diabetes in Kelantan.
Q33578588Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1.
Q43886987Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages
Q42365354TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1
Q37782506Targeting β-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus
Q37088103Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs
Q35337771Telemedicine security: a systematic review
Q34430055Temporal trends of hemoglobin A1c testing
Q35127906Tendon repair is compromised in a high fat diet-induced mouse model of obesity and type 2 diabetes
Q39434269The Costs of Fall-Related Injuries among Older Adults: Annual Per-Faller, Service Component, and Patient Out-of-Pocket Costs
Q30723404The Effect of Counseling on Cataract Patient Knowledge, Decisional Conflict, and Satisfaction
Q57701988The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
Q37449172The diabetes epidemic and its effect on cardiac surgery practice
Q37424026The effect of cumulative glycemic burden on the incidence of diabetic foot disease
Q34174390The use of clinical guidelines highlights ongoing educational gaps in physicians' knowledge and decision making related to diabetes
Q35866737Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration
Q39110724Transitioning the Adult with Type 2 Diabetes From the Acute to Chronic Care Setting: Strategies to Support Pragmatic Implementation Success.
Q33858652Trends and stabilization up to 2022 in overweight and obesity in Switzerland, comparison to France, UK, US and Australia
Q51023486Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative.
Q36464788Type 2 Diabetes Genetics: Beyond GWAS.
Q35613893Type 2 diabetes among Asian Americans: Prevalence and prevention
Q44749291Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study
Q38833948Type 2 diabetes mellitus unawareness, prevalence, trends and risk factors: National Health and Nutrition Examination Survey (NHANES) 1999-2010.
Q51155310Unintentional therapeutic errors involving insulin in the ambulatory setting reported to poison centers.
Q37890781Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus
Q36803259Variation in ultraviolet radiation and diabetes: evidence of an epigenetic effect that modulates diabetics' lifespan.
Q27687558Weight control and prevention of metabolic syndrome by green tea.
Q53395294What is the cost of quality for diabetes care?

Search more.